The use of positron emission tomography (PET) is not sensitive enough to warrant routine use in post-curative chemoradiation therapy diagnosis of patients with node-positive head and neck cancer, according to researchers in the field.
![](https://www.enttoday.org/wp-content/uploads/springboard/image/2006_04_17.gif)
The use of positron emission tomography (PET) is not sensitive enough to warrant routine use in post-curative chemoradiation therapy diagnosis of patients with node-positive head and neck cancer, according to researchers in the field.